Biomarker Qualification: Toward a Multiple Stakeholder Framework for Biomarker Development, Regulatory Acceptance, and Utilization.
about
microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessmentCerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker TeamThe Traumatic Brain Injury Endpoints Development (TED) Initiative: Progress on a Public-Private Regulatory Collaboration to Accelerate Diagnosis and Treatment of Traumatic Brain Injury.Industry perspectives on biomarker qualification.Conjunctival Neutrophils Predict Progressive Scarring in Ocular Mucous Membrane Pemphigoid.Building a roadmap to biomarker qualification: challenges and opportunities.Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage.Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations.Addressing the Crisis in the Treatment of Osteoporosis: A Path Forward.Promoting Adoption of the 3Rs through Regulatory Qualification.Beyond Correlations, Sensitivities, and Specificities: A Roadmap for Demonstrating Utility of Advanced Imaging in Oncology Treatment and Clinical Trial Design.Evidence for Treatment-by-Biomarker interaction for FDA-approved Oncology Drugs with Required Pharmacogenomic Biomarker Testing.A new role for evoked potentials in MS? Repurposing evoked potentials as biomarkers for clinical trials in MS.The 5th Annual One Mind Summit: Lessons Learned About "Science Informing Brain Health Policies and Practice".Accelerating drug development for Alzheimer's disease through the use of data standardsWearable Devices in Clinical Trials: Hype and Hypothesis.Biomarkers: Delivering on the expectation of molecularly driven, quantitative health.What evidence do we need for biomarker qualification?Exploring Erythrocytes as Blood Biomarkers for Alzheimer's Disease.Combination Therapy for Multi-Target Manipulation of Secondary Brain Injury Mechanisms.Industry Perspective on Biomarker Development and Qualification.Regulatory landscapes for biomarkers and diagnostic tests: Qualification, approval, and role in clinical practice.Biosignature Discovery for Substance Use Disorders Using Statistical Learning.
P2860
Q26778918-F38ADCA6-D143-401E-A83B-7AF40CC1694FQ28595520-1E2F7AAA-E8E2-4FA1-AB59-C54129150CEBQ36330425-CA36A373-B057-4852-BEDE-D84D5C76EBCEQ37341324-6F255132-68FF-4CF6-9BAE-90E590C13F0FQ37354234-5FCECB5B-23A0-418C-B49E-23BD7C329136Q38622968-516F95F8-F941-47ED-9EB0-44D1C3F8E0A9Q38632703-47D06DAA-2650-4F1C-8573-37F3B1F1F211Q38640436-3E9A6E5B-ABDA-49A3-9573-D21902AC4E15Q39014377-5DC13A5D-90AE-4548-953A-50087E254D4FQ39039967-D5AF30C5-9D9E-4124-A6AC-C09A40584D14Q39272347-C442C198-9634-44D5-8EE5-D03CED224F24Q40100583-B16DC8D7-3697-4CC1-89F6-CC15368DEF28Q41473773-2E1086A5-9713-4421-89EB-2AF66A940B0AQ42380225-EC4E729A-76DD-4480-A62D-141CF6232BA4Q42655623-2245584A-EB2F-4EFE-96C1-FE5422578957Q47368463-F8373371-895A-4861-AF5C-B594C2B6FA9BQ47377237-C46876DA-7D04-429A-BDCC-09C2FFD8451BQ47571617-AB55A7AF-2A09-4836-9C31-351AD9507BCAQ47687712-3DEDE005-AB80-4CB8-A522-3CD8B55EA74CQ47711481-B669887C-716F-4D05-B9D6-3A09DA518887Q49969133-B9474595-D20D-45D0-8787-2B1D549E32AFQ50128663-3FA9DEC5-5694-4CD8-A615-A38FF675C7DCQ50154619-E6FCF7C2-3CA4-4D8F-B4C3-05E80B6C1A89
P2860
Biomarker Qualification: Toward a Multiple Stakeholder Framework for Biomarker Development, Regulatory Acceptance, and Utilization.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Biomarker Qualification: Towar ...... y Acceptance, and Utilization.
@en
type
label
Biomarker Qualification: Towar ...... y Acceptance, and Utilization.
@en
prefLabel
Biomarker Qualification: Towar ...... y Acceptance, and Utilization.
@en
P2093
P2860
P356
P1476
Biomarker Qualification: Towar ...... y Acceptance, and Utilization.
@en
P2093
P2860
P356
10.1002/CPT.136
P407
P577
2015-06-06T00:00:00Z